Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 20.86 M

Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow is USD 20.86 M for the year ending December 31, 2023, a 198.66% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -21.14 M, a -228.41% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 16.47 M, a -12.85% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 18.89 M, a 323.21% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 4.46 M, a -72.45% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years